These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32421916)

  • 21. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
    Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
    J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactomedin-4 autoantibodies give unusual c-ANCA staining patterns with reactivity to a subpopulation of neutrophils.
    Amirbeagi F; Thulin P; Pullerits R; Pedersen B; Andersson BA; Dahlgren C; Welin A; Bylund J
    J Leukoc Biol; 2015 Jan; 97(1):181-9. PubMed ID: 25387833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis.
    Gross WL; Csernok E
    Curr Opin Rheumatol; 1995 Jan; 7(1):11-9. PubMed ID: 7718417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.
    Xu PC; Gou SJ; Yang XW; Cui Z; Jia XY; Chen M; Zhao MH
    BMC Immunol; 2012 Mar; 13():10. PubMed ID: 22404873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
    Jennette JC; Xiao H; Falk RJ
    J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies.
    O'Brien EC; Abdulahad WH; Rutgers A; Huitema MG; O'Reilly VP; Coughlan AM; Harrington M; Heeringa P; Little MA; Hickey FB
    Sci Rep; 2015 Jul; 5():11888. PubMed ID: 26149790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils.
    Hsieh SC; Yu HS; Cheng SH; Li KJ; Lu MC; Wu CH; Tsai CY; Yu CL
    Clin Rheumatol; 2007 Feb; 26(2):216-24. PubMed ID: 16575489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation.
    Jerke U; Rolle S; Dittmar G; Bayat B; Santoso S; Sporbert A; Luft F; Kettritz R
    J Biol Chem; 2011 Mar; 286(9):7070-81. PubMed ID: 21193407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
    Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
    Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
    Surmiak M; Kaczor M; Sanak M
    J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modify their apoptosis.
    Deutsch M; Guejes L; Zurgil N; Shovman O; Gilburd B; Afrimzon E; Shoenfeld Y
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S35-40. PubMed ID: 15675133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis.
    Jennette JC; Falk RJ; Gasim AH
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):263-70. PubMed ID: 21422922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of ANCA-associated vasculitis.
    Flint J; Morgan MD; Savage CO
    Rheum Dis Clin North Am; 2010 Aug; 36(3):463-77. PubMed ID: 20688244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.
    Porges AJ; Redecha PB; Kimberly WT; Csernok E; Gross WL; Kimberly RP
    J Immunol; 1994 Aug; 153(3):1271-80. PubMed ID: 8027554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
    Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
    J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenic role of antineutrophil cytoplasmic autoantibodies.
    Ewert BH; Jennette JC; Falk RJ
    Am J Kidney Dis; 1991 Aug; 18(2):188-95. PubMed ID: 1651049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis.
    Moxey J; Huq M; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Ross L; Major G; Roddy J; Stevens W; Nikpour M
    Arthritis Res Ther; 2019 Feb; 21(1):57. PubMed ID: 30764870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
    Falk RJ; Terrell RS; Charles LA; Jennette JC
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4115-9. PubMed ID: 2161532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antineutrophil cytoplasmic autoantibodies antigen specificity.
    Lesavre P
    Am J Kidney Dis; 1991 Aug; 18(2):159-63. PubMed ID: 1714231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.